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Letter to the editor: 
STEM CELL-BASED TEST METHODS 
 
Florian Seidel, Leibniz Research Centre for Working Environment and Human Factors,  









Dear Editor,  
Recently, Agapios Sachinidis and colleagues from the University of Cologne published a 
review about possibilities and limitations of stem cell-based test methods in pharmacology and 
toxicology (Sachinidis et al., 2019). In recent years, much progress has been achieved concern-
ing in vitro techniques of liver (Godoy et al., 2013; Grinberg et al., 2014; Leist et al., 2017; 
Ghallab et al., 2016), kidney (Sjögren et al., 2018; Jiang et al., 2018; Su et al., 2016; Valente et 
al., 2012; Lee et al., 2017), neuronal (Keil et al., 2018; Yang et al., 2018; Colaianna et al., 2017; 
Sisnaiske et al., 2014) and developmental toxicity (Adam et al., 2019; Bridges et al., 2019; 
Abbott, 2019). Particularly, in developmental and reproductive toxicity testing, large numbers 
of animals are needed for analysis of a single compound (Krug et al., 2013). Therefore, stem 
cell-based test systems are currently developed (Shinde et al., 2014, 2015, 2016; Krug et al., 
2013; Meganathan et al., 2012). They recapitulate differentiation into cells of the three germ 
layers (Meganathan et al., 2012; Shinde et al., 2016, 2017) or differentiation into neural ecto-
dermal progenitor cells (Rempel et al., 2015; Waldmann et al., 2014). Stem cells are exposed 
to test compounds during the differentiation process and compound associated gene expression 
changes are monitored.  
Indices have been developed to identify a possible hazard of developmental toxicity based 
on genome-wide expression data. A precondition is the definition of so-called developmental 
genes of a test system. Developmental genes are up- or down-regulated during the differentia-
tion process in the absence of test compounds. Developmental potency describes the fraction 
of all developmental genes, whose expression is altered by test compounds (Shinde et al., 2017). 
Although large validation studies are still required, several developmental toxicants, e.g. tha-
lidomide and valproic acid, have been successfully differentiated from negative control com-
pounds (Meganathan et al., 2012; Waldmann et al., 2014).  
Much progress has been achieved in analyzing disturbed developmental processes. How-
ever, it still remains challenging to differentiate stem cells to adult cell types that closely re-
semble the corresponding mature cell type in vivo (Godoy et al., 2015; Cameron et al., 2015). 
The authors of the present review describe why this is so difficult, using stem cell derived 
hepatocyte-like cells as an example (Sachinidis et al., 2019). Problems are due to incomplete 
endoderm patterning (Zorn, 2008; Gordillo et al., 2015) and to still suboptimal protocols to 
trigger the final differentiation of hepatoblasts to mature hepatocytes.  
Stem cell-based alternative test methods offer powerful tools to analyze developmental tox-
icity in vitro, but there is still a long way to go until the techniques are ready for routine use 
and to replace animal studies in pharmacology and toxicology.  
 
 
EXCLI Journal 2019;18:442-444 – ISSN 1611-2156 




Conflict of interest 
The author declares no conflict of interest. 
 
REFERENCES 
Abbott BD. Embryonic midfacial palatal organ culture 
methods in developmental toxicology. Meth Mol Biol. 
2019;1965:93-105.  
Adam AHB, Zhang M, de Haan LHJ, van Ravenzwaay 
B, Louisse J, Rietjens IMCM. The in vivo developmen-
tal toxicity of diethylstilbestrol (DES) in rat evaluated 
by an alternative testing strategy. Arch Toxicol. 2019 
May 22. doi: 10.1007/s00204-019-02487-6. [Epub 
ahead of print]. 
Bridges KN, Magnuson JT, Curran TE, Barker A, Rob-
erts AP, Venables BJ. Alterations to the vision-associ-
ated transcriptome of zebrafish (Danio rerio) following 
developmental norethindrone exposure. Environ Toxi-
col Pharmacol. 2019;69:137-142. 
Cameron K, Tan R, Schmidt-Heck W, Campos G, Ly-
all MJ, Wang Y, et al. Recombinant laminins drive the 
differentiation and self-organization of hESC-derived 
hepatocytes. Stem Cell Reports. 2015;5:1250-62. 
Colaianna M, Ilmjärv S, Peterson H, Kern I, Julien S, 
Baquié M, et al. Fingerprinting of neurotoxic com-
pounds using a mouse embryonic stem cell dual lumi-
nescence reporter assay. Arch Toxicol. 2017;91:365-
91. 
Ghallab A, Cellière G, Henkel SG, Driesch D, Hoehme 
S, Hofmann U, et al. Model-guided identification of a 
therapeutic strategy to reduce hyperammonemia in 
liver diseases. J Hepatol. 2016;64:860-71.  
Godoy P, Hewitt NJ, Albrecht U, Andersen ME, An-
sari N, Bhattacharya S, et al. Recent advances in 2D 
and 3D in vitro systems using primary hepatocytes, al-
ternative hepatocyte sources and non-parenchymal 
liver cells and their use in investigating mechanisms of 
hepatotoxicity, cell signaling and ADME. Arch Toxi-
col. 2013;87:1315-530. 
Godoy P, Schmidt-Heck W, Natarajan K, Lucendo-
Villarin B, Szkolnicka D, Asplund A, et al. Gene net-
works and transcription factor motifs defining the dif-
ferentiation of stem cells into hepatocyte-like cells. J 
Hepatol. 2015;63:934-42. 
Gordillo M, Evans T, Gouon-Evans V. Orchestrating 
liver development. Development. 2015;142:2094-108.  
Grinberg M, Stöber RM, Edlund K, Rempel E, Godoy 
P, Reif R, et al. Toxicogenomics directory of chemi-
cally exposed human hepatocytes. Arch Toxicol. 
2014;88:2261-87.  
Jiang S, Lin Y, Yao H, Yang C, Zhang L, Luo B, et al. 
The role of unfolded protein response and ER-phagy in 
quantum dots-induced nephrotoxicity: an in vitro and 
in vivo study. Arch Toxicol. 2018;92:1421-34.  
Keil KP, Miller GW, Chen H, Sethi S, Schmuck MR, 
Dhakal K, et al. PCB 95 promotes dendritic growth in 
primary rat hippocampal neurons via mTOR-depend-
ent mechanisms. Arch Toxicol. 2018;92:3163-73. 
Krug AK, Kolde R, Gaspar JA, Rempel E, Balmer NV, 
Meganathan K, et al. Human embryonic stem cell-de-
rived test systems for developmental neurotoxicity: a 
transcriptomics approach. Arch Toxicol. 2013;87:123-
43.  
Lee WK, Probst S, Santoyo-Sánchez MP, Al-Hamdani 
W, Diebels I, von Sivers JK, et al. Initial autophagic 
protection switches to disruption of autophagic flux by 
lysosomal instability during cadmium stress accrual in 
renal NRK-52E cells. Arch Toxicol. 2017;91:3225-45. 
Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, 
Bennekou SH, et al. Adverse outcome pathways: op-
portunities, limitations and open questions. Arch Tox-
icol. 2017;91:3477-505. 
Meganathan K, Jagtap S, Wagh V, Winkler J, Gaspar 
JA, Hildebrand D, et al. Identification of thalidomide-
specific transcriptomics and proteomics signatures dur-
ing differentiation of human embryonic stem cells. 
PLoS One. 2012;7(8):e44228.  
Rempel E, Hoelting L, Waldmann T, Balmer NV, 
Schildknecht S, Grinberg M, et al. A transcriptome-
based classifier to identify developmental toxicants by 
stem cell testing: design, validation and optimization 
for histone deacetylase inhibitors. Arch Toxicol. 
2015;89:1599-618.  
Sisnaiske J, Hausherr V, Krug AK, Zimmer B, 
Hengstler JG, Leist M, et al. Acrylamide alters neuro-
transmitter induced calcium responses in murine ESC-
derived and primary neurons. Neurotoxicology. 
2014;43:117-26. 
Sachinidis A, Albrecht W, Nell P, Cherianidou A, 
Hewitt N, Edlund K, et al. Road map for development 
of stem cell-based alternative test methods. Trends Mol 
Med. 2019, doi: 10.1016/j.molmed.2019.04.003. 
[Epub ahead of print].  
Shinde V, Chaudhari U, Sotiriadou I, Hescheler J, Sa-
chinidis A. In vitro methods for cardiotoxicity testing. 
In:Bal-Price A, Jennings P (eds): In vitro toxicology 
systems (pp 45-77). New York: Springer, 2014. 
Shinde V, Klima S, Sureshkumar PS, Meganathan K, 
Jagtap S, Rempel E, et al. Human pluripotent stem cell 
based developmental toxicity assays for chemical 
EXCLI Journal 2019;18:442-444 – ISSN 1611-2156 




safety screening and systems biology data generation. 
J Vis Exp. 2015;100:e52333.  
Shinde V, Sureshkumar P, Sotiriadou I, Hescheler J, 
Sachinidis A. Human embryonic and induced pluripo-
tent stem cell based toxicity testing models: future ap-
plications in new drug discovery. Curr Med Chem. 
2016;23:3495-509. 
Shinde V, Hoelting L, Srinivasan SP, Meisig J, Mega-
nathan K, Jagtap S, et al. Definition of transcriptome-
based indices for quantitative characterization of 
chemically disturbed stem cell development: introduc-
tion of the STOP-Toxukn and STOP-Toxukk tests. 
Arch Toxicol. 2017;91:839-64. 
Sjögren AK, Breitholtz K, Ahlberg E, Milton L, 
Forsgard M, Persson M, et al. A novel multi-parametric 
high content screening assay in ciPTEC-OAT1 to pre-
dict drug-induced nephrotoxicity during drug discov-
ery. Arch Toxicol. 2018;92:3175-90.  
Su R, Xiong S, Zink D, Loo LH. High-throughput im-
aging-based nephrotoxicity prediction for xenobiotics 
with diverse chemical structures. Arch Toxicol. 
2016;90:2793-808. 
Valente MJ, Henrique R, Vilas-Boas V, Silva R, 
Bastos Mde L, Carvalho F, et al. Cocaine-induced kid-
ney toxicity: an in vitro study using primary cultured 
human proximal tubular epithelial cells. Arch Toxicol. 
2012;86:249-61. 
Waldmann T, Rempel E, Balmer, N, König, A, Kolde, 
R, Gaspar, JA, et al. Design principles of concentra-
tion-dependent transcriptome deviations in drug-ex-
posed differentiating stem cells. Chem Res Toxicol. 
2014;27:408-20. 
Yang B, Bai Y, Yin C, Qian H, Xing G, Wang S, et al. 
Activation of autophagic flux and the Nrf2/ARE sig-
naling pathway by hydrogen sulfide protects against 
acrylonitrile-induced neurotoxicity in primary rat as-
trocytes. Arch Toxicol. 2018;92:2093-108. 
Zorn AM. Liver development (October 31, 2008). In: 
StemBook. Cambridge, MA: Harvard Stem Cell Insti-
tute, 2008. 
 
 
